User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
 Views 12
 Downloands 4
Investigation of the Antiviral Effect of Vepesid on HSV Type 2
2002
Journal:  
Turkish Journal of Medical Sciences
Author:  
Abstract:

Objective: Vepesid is a semisynthetic derivative of phodophylotoxin extracted from Phodophylum peltatum, which is in the group of plant alkaloids. In this study, the antiviral effect of Vepesid against herpes simplex virus type 2 (HSV-2) in in vitro conditions was investigated. Materials and Methods: In this investigation, a HEp-2 continuous cell line that was derived from human larynx cancer cells was used. The experiments were done in culture plates with smooth bases consisting of 96 wells. Cultivation of cells was realized in EMEM medium with 10% fetal bovine serum at an atmosphere of 37°C with 5% CO2. The toxicity of investigated agents and sensitivity of HEp-2 cells were evaluated according to the Reed and Muench method. The 50% effective dose (ED50) of the antiviral agent was expressed as the concentration that inhibits the cytopathological effect in half of the quadruplicate test cultures. Acyclovir was included as a positive control drug for HSV. The experiments were done in two stages. In the first stage, the concentration of Vepesid that did not affect proliferation was determined by means of morphological and biochemical parameters (pH, pCO2, pO2, Na+). In the second stage, the antiviral effect of that dose was examined on 100 TCID{50} of HSV-2. Results: The concentrations of Acyclovir and Vepesid (3.12 µg/ml, 6.28 µg/ml) were toxic and 1.56 µg/ml of both agents did not affect cell proliferation. These amounts of Acyclovir and Vepesid inhibited viral reproduction and had no cytopathological effect on cells. Na+ content of the culture medium was 138 ± 2.54 mEq/L for the control group, 126 ± 1.65 mEq/L for the virus control, 142 ± 0.3 for the Acyclovir, 142 ± 0.4 for the Acyclovir + virus, 143 ± 1.1 for Vepesid, 141 ± 0.2 for the virus + Vepesid. LD50 of Acyclovir and Vepesid was found to be 71% for a virus titer of 100 TCID50. Conclusion: We found that Vepesid prevented the viral replication of herpes simplex virus type 2. We think that the study of Vepesid as the treatment for patients with herpes simplex virus (HSV) is very important in terms of its clinical and epidemiological nature.

Keywords:

Citation Owners
Information: There is no ciation to this publication.
Similar Articles












Turkish Journal of Medical Sciences

Field :   Sağlık Bilimleri

Journal Type :   Uluslararası

Metrics
Article : 4.115
Cite : 3.307
2023 Impact : 0.011
Turkish Journal of Medical Sciences